Related party transactions |
12 Months Ended |
|---|---|
Jan. 31, 2024 | |
| Related Party Transactions [Abstract] | |
| Related party transactions | Related party transactions For the years ended January 31, 2024 and 2023, the Company recognized revenue totaling $1,174 and $775, respectively, for advertisements placed by a pharmaceutical company. One of the Company's independent members of its board of directors serves on the board of directors for this pharmaceutical company. As of January 31, 2024 and 2023, accounts receivable from the pharmaceutical company totaled $416 and $339, respectively. For the years ended January 31, 2024 and 2023, the Company recognized general and administrative expenses totaling $118 and $374, respectively, for software agreements with a software company. One of the Company's independent members of its board of directors served as the chief executive officer and on the board of directors for this software company until May 2023. This Company is no longer considered a related party subsequent to May 2023. As of January 31, 2023, prepaid expenses and other current assets included approximately $51 of payments to this software company. One of the Company's independent members of its board of directors has served as the chief financial officer of a software company since April 2022. The Company recognized de minimis expenses during the year ended January 31, 2024 for software agreements with this software company.
|